Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global viscosupplementation market was valued at US$ 1.87 billion in 2022 and is expected to register a revenue CAGR of 4.66% to reach US$ 6.14 billion by 2031.

Viscosupplementation Market Fundamentals

Viscosupplementation is a medical procedure used to treat osteoarthritis, particularly in the knee joint. It involves injecting a thick fluid called hyaluronic acid (HA) directly into the joint to improve lubrication and reduce pain. Viscosupplementation aims to restore the viscosity and lubricating properties of the joint fluid by injecting HA directly into the knee joint. The procedure involves several injections spaced out over a few weeks. The exact number of injections and the specific HA product used may vary depending on the severity of the osteoarthritis and the healthcare provider's preference. Viscosupplementation is typically considered for patients with mild to moderate osteoarthritis who have not responded well to conservative treatments such as physical therapy, pain medications, and corticosteroid injections. 

The research study on the viscosupplementation market overview thoroughly analyzes the market, along with the aspects that either help or hinder the market's growth, such as its drivers, challenges, and opportunities. The research also discusses the list of businesses that operate in this market and their efforts to establish themselves as major players through expansion plans and innovative ideas. It also emphasizes current events that support the market's revenue expansion. 

This report is an important tool for the industry stakeholders to gather all the information about the market, customers, and competition. The report also provides the readers with valuable insights on the segmentation, regions, market size & forecast, revenue CAGRs, and other valuable data to help make informed strategic decisions. The study compiles information gathered from industry participants and specialists across the industry value chain. The report also taps into the qualitative and quantitative assessments by industry analysts. Our reports use different methods for estimating the market size and forecast, including secondary research, surveys and interviews, and statistical modeling. With these steps, our reports provide the most accurate market data. These datasets will cumulatively provide an in-depth viscosupplementation market forecast to the industry stakeholders.

[865785]

Viscosupplementation Market Dynamics

Osteoarthritis is a common degenerative joint disease affecting millions of people worldwide. The rising prevalence of osteoarthritis, particularly in the aging population, has been a significant driver for the viscosupplementation market. For instance, according to the 2020 “Lancet” report, the estimated prevalence was 19⋅2% in Asia, 13⋅4% in Europe, 15⋅8% in North America, 4⋅1% in South America, 3⋅1% in Oceania, and 21⋅0% in Africa. As the population ages, the demand for effective treatments for osteoarthritis is expected to increase. There has been a growing awareness among both patients and healthcare professionals about viscosupplementation as a treatment option for osteoarthritis. As more clinical evidence and positive patient experiences become available, the adoption of viscosupplementation as a viable treatment has been improved. This increased awareness has contributed to the growth of the market.

Furthermore, manufacturers have been investing in research and development to improve the efficacy and safety of viscosupplementation products. This has led to the introduction of new and improved formulations of hyaluronic acid, such as high molecular weight HA and cross-linked HA. These advancements have helped enhance the outcomes of viscosupplementation procedures, further driving the market growth. 

Moreover, viscosupplementation offers a non-surgical and minimally invasive alternative to more invasive treatments for osteoarthritis, such as joint replacement surgery. With a growing emphasis on less invasive procedures and a desire for quicker recovery times, viscosupplementation has gained popularity among patients and healthcare providers. The development of advanced injection techniques, such as ultrasound-guided injections, has improved the accuracy and effectiveness of viscosupplementation procedures. These techniques allow for better targeting and precise delivery of the hyaluronic acid into the joint, enhancing patient outcomes and satisfaction. Hyaluronic acid, the main component of viscosupplementation, is also used in cosmetic procedures such as dermal fillers. The increasing demand for minimally invasive cosmetic treatments, coupled with the familiarity and safety of hyaluronic acid, has indirectly contributed to the growth of the viscosupplementation market.

Reimbursement policies and insurance coverage for viscosupplementation have improved in some regions. This has made the procedure more accessible and affordable for patients, contributing to market growth. 

Viscosupplementation Market Ecosystem

Viscosupplementation Market, Product

• Three Injection
• Single Injection
• Five Injection

Viscosupplementation Market, by End User

• Hospitals
• Ambulatory Surgical Centers
• Others

Viscosupplementation Market by Product

[235345]

Single injection segment dominates the global market with a revenue market share of over 46.08%.  Single-injection viscosupplementation offers the advantage of a shorter treatment duration compared to multiple-injection regimens. Patients often prefer a single injection over multiple injections, as it reduces the overall treatment burden and inconvenience. It can particularly benefit patients with difficulty adhering to a multi-injection schedule. Single-injection regimens can enhance patient compliance, eliminating the need for patients to return for multiple treatment sessions. Patients are more likely to complete the entire treatment course when it requires only one visit, leading to better clinical outcomes. Single injection viscosupplementation can also be more cost-effective compared to multiple injections. Although the upfront cost per injection could be higher, the total cost of treatment, including clinic visits and associated expenses, is generally lower with a single injection. This can make it a more appealing option for patients and healthcare systems aiming to optimize resource utilization. Advancements in the formulation and technology of single injection viscosupplementation have improved the treatment's efficacy and durability. Modern single injection products often have longer-lasting effects, providing sustained pain relief and functional improvement for an extended period. This has contributed to the growing preference for single injection options among patients and healthcare providers.

Segmentation of the market refers to the division of the industry into subgroups based on factors such as product, end user, and region. Market segmentation data helps businesses to understand the preferences and unique needs of different customer groups and develop targeted sales strategies. This information also helps in identifying potential muscarinic agonist market growth opportunities.

Viscosupplementation Market by Region

Based on region, the global viscosupplementation market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounts for the largest revenue share in the global market. North America has a significant burden of osteoarthritis, with a large population affected by the disease. For instance, according to 2020 “Lancet” report, it was registered that incidence were approximately 130 per 10,000 person-years in the United States suffering from osteoarthritis. Osteoarthritis is a leading cause of disability in the region, particularly among the aging population. The high prevalence of osteoarthritis drives the demand for effective treatments such as viscosupplementation. According to the research done by “Osteoarthritis Action Allaince”, it was estimated that one in every four U.S. individuals suffer from one of the types of arthritis, a ratio that is expected to rise to 78 million by the year 2040. While there are more than 100 different forms of arthritis, osteoarthritis (OA) is the most prevalent, affecting 32.5 million US people.

North America is known for its advanced healthcare infrastructure, including well-established medical facilities, research institutions, and a strong pharmaceutical industry. This enables efficient distribution and access to viscosupplementation products and supports the growth of the market. The region's healthcare systems, particularly in the United States, often have favorable reimbursement policies for viscosupplementation procedures. Insurance coverage and reimbursement support make the treatment more accessible and affordable for patients, driving market growth. There is a high level of awareness and acceptance of viscosupplementation among healthcare professionals and patients in North America. Ongoing medical education, clinical research, and patient advocacy contribute to the understanding and adoption of viscosupplementation as a viable treatment option. North America has been at the forefront of technological advancements in viscosupplementation. The region sees early adoption and availability of new and improved products, formulations, and injection techniques. This leads to better treatment outcomes and patient satisfaction, further driving the market. There is a growing preference for minimally invasive treatments in North America, driven by factors such as shorter recovery times, reduced hospital stays, and improved patient comfort. Viscosupplementation, being a non-surgical and minimally invasive procedure, aligns with this trend and contributes to its dominance in the market.

Based on the regions, the global viscosupplementation market is segmented into:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Regional demarcation of the industry will provide information on geographic pockets regarding viscosupplementation market outlook, size, share, and growth rate. This data helps businesses evaluate the expansion potential into new regional markets, understand the competitive threats across different regions, and develop localized sales and expansion strategies.

Competitive Landscape

The prominent players operating in the viscosupplementation market are:

• Zimmer Biomet Holdings Inc.
• Sanofi S.A.
• OrthogenRx Inc.
• Seikagaku Corporation
• Aptissen
• Seikagaku Corporation
• Wellchem Pharmaceuticals Pte Ltd.
• Anika Therapeutics Inc.
• Chugai Pharmaceuticals Co., Ltd.
• Ferring Pharmaceuticals

Key Strengths of Our Report 

• Forecast till 2031
• Cross-sectional Coverage Across 14 Countries
• Consumer Level Segmentation
• Regulatory Landscape
• Key Cross Competition
• Unmet Needs
• Market Attractiveness
• Analysis of Pipeline Prospects
• Market Drivers and Challenges

Target Audience to Benefit from this Report.

• New entrants to the market, start-ups, investors, and equity firms
• Manufacturers, distributors, developers, and regulators of products. Research and consulting firms
• Associations and governmental bodies 
• Business associations, forums, lobbying groups, and reporting organizations

Reasons to Buy this Report

• Detailed analysis of the impact of the COVID-19 pandemic on the global viscosupplementation market
• Develop your growth strategies by reviewing the prevalent market trends, innovations, segment analysis, regional market landscape, and future opportunities.
• Information on relevant laws and regulations that impact on the market, such as product safety standards or import/export regulations.
• Understanding the market's future competitive landscape and providing an insightful analysis of the major industry drivers and obstacles.
• Identify the competitive landscape of the global market and understand the intensity of competition. 
• Finding established and promising new competitors in the market will aid in creating competitive advantage tactics.
• Track the revenue growth of the global, regional, and country-level markets and make effective expansion decisions.
• Strategize sales and marketing goals by determining the most premium opportunities in the colorectal cancer screening market.
• Evaluate potential return on investment for new products or services by analyzing CAGR data, businesses can evaluate the potential return on investment.
• Our robust sources and research methodologies deliver accurate market sizing and forecast, which are further validated by authentic primary sources, including CMOs from major market players and key opinion leaders.

Frequently Asked Questions About This Report